Roivant Sciences Ltd (ROIV) showcases robust financial health with $5.4 billion in cash and no debt, while navigating competitive pressures and strategic opportunities.
The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback